Landos Biopharma, Inc. Marketable Securities, Current in USD from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
Landos Biopharma, Inc. quarterly Marketable Securities, Current history and growth rate from Q4 2020 to Q4 2023.
  • Landos Biopharma, Inc. Marketable Securities, Current for the quarter ending December 31, 2023 was $0.000, a 100% decline year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Growth (%)

Landos Biopharma, Inc. Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q4 2023 $0 -$7.76M -100% Dec 31, 2023 10-K 2024-03-21
Q3 2023 $62K -$19M -99.7% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $687K -$35.8M -98.1% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $4.76M -$57.7M -92.4% Mar 31, 2023 10-Q 2023-05-12
Q4 2022 $7.76M -$74.8M -90.6% Dec 31, 2022 10-K 2024-03-21
Q3 2022 $19.1M -$65.7M -77.5% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $36.5M -$59.9M -62.1% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $62.5M -$35.3M -36.1% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $82.6M +$56.9M +221% Dec 31, 2021 10-K 2023-03-23
Q3 2021 $84.8M Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $96.4M Jun 30, 2021 10-Q 2021-07-29
Q1 2021 $97.8M Mar 31, 2021 10-Q 2021-05-17
Q4 2020 $25.7M Dec 31, 2020 10-K 2022-03-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.